XML 34 R24.htm IDEA: XBRL DOCUMENT v3.25.3
Net Loss Per Share
9 Months Ended 12 Months Ended
Sep. 30, 2025
Dec. 31, 2024
Earnings Per Share [Abstract]    
Net Loss Per Share
Note 18. Net Loss Per Share
The following table sets forth the computation of basic and dilutive net loss per share:
 
    
Three Months Ended
September 30,
   
Nine Months Ended
September 30,
 
(Amounts in thousands, except share and per share
amounts)
  
2025
   
2024
   
2025
   
2024
 
Numerator:
        
Net loss
   $ (26,258   $ (25,607   $ (203,608   $ (54,503
Denominator:
        
Weighted average shares outstanding, basic and diluted
(1)
     103,585,681       17,478,371       100,130,737       17,466,606  
  
 
 
   
 
 
   
 
 
   
 
 
 
Net loss per share, basic and diluted
   $ (0.25   $ (1.47   $ (2.03   $ (3.12
  
 
 
   
 
 
   
 
 
   
 
 
 
 
(1)
 
Three and nine months ended September 30, 2025 include 1,944,865 vested but unissued shares underlying awards of RSUs to employees and 28,500 vested RSUs but unissued shares underlying awards of RSUs to advisors. The Company is contractually obligated to issue shares of common stock for all vested but unissued RSUs.
Net loss per share calculations and potentially dilutive security amounts for all periods prior to the closing of the Merger have been retrospectively adjusted to the equivalent number of shares outstanding immediately after the Merger to effect the reverse recapitalization. Historically reported weighted average shares outstanding have been multiplied by the Exchange Ratio of approximately 0.78.
The following potentially dilutive securities were excluded from the calculation of diluted net loss per share attributable to common shareholders for the periods presented because the impact of including them would have been anti-dilutive or out-of-the-money:
 
    
Three Months Ended
September 30,
    
Nine Months Ended
September 30,
 
    
2025
    
2024
    
2025
    
2024
 
Stock options
     29,318,783        12,736,621        29,318,783        12,736,621  
RSUs
     8,791,483        3,743,578        8,791,483        3,743,578  
Earnout shares
     17,600,000        —         17,600,000        —   
Common stock warrants
     50,000        —         50,000        —   
Public warrants
     28,750,000        —         28,750,000        —   
Private warrants
     898,250        —         898,250        —   
Redeemable convertible preferred stock
     —         34,702,999        —         34,702,999  
Legacy warrants
     —         4,695,604        —         4,695,604  
  
 
 
    
 
 
    
 
 
    
 
 
 
Total potentially dilutive shares
     85,408,516        55,878,802        85,408,516        55,878,802  
  
 
 
    
 
 
    
 
 
    
 
 
 
Note 14. Net Loss Per Share Attributable to Common Shareholders
The following table sets forth the computation of basic and dilutive net loss per share attributable to common stockholders for the years ended December 31, 2024 and 2023:
 
 
  
2024
 
 
2023
 
Numerator:
     
Net loss
   $ (61,195    $ (87,589
  
 
 
    
 
 
 
Denominator:
     
Weighted-average number of shares outstanding used to compute net loss per share attributable to common stockholders, basic and diluted
     17,476,105        4,213,244  
  
 
 
    
 
 
 
Net loss per share attributable to common stockholders, basic and diluted
   $ (3.50    $ (20.79
  
 
 
    
 
 
 
The following potentially dilutive securities were excluded from the calculation of diluted net loss per share attributable to common shareholders for the periods presented because the impact of including them would have been anti-dilutive for the years ended December 31, 2024 and 2023:
 
 
  
2024
 
 
2023
 
Redeemable convertible preferred stock
     44,494,703        44,494,703  
Stock options
     36,363,184        16,437,980  
Restricted stock units
     4,655,274        4,916,829  
Series D and
D-2
preferred stock warrants
     756,172        1,094,667  
Pay-to-Play
warrants (estimated See Note 8)
     1,127,088        721,086  
Convertible Notes warrants - 2023
    
(a)
 
   
(a)
 
Common stock warrants
     —         2,063  
Pre-funded
warrant (estimated See Note 8)
     2,000,000        7,007,582  
Pre-funded
warrant April 2024 (estimated See Note 8)
     4,500,000        —   
  
 
 
    
 
 
 
Total potentially dilutive shares
     93,896,421        74,674,910  
  
 
 
    
 
 
 
 
(a)
 
The number of warrants shares to be issued upon exercise of the 2023 Convertible Note Warrants is not determinable due to the variable settlement terms (see Note 8).